Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease.
about
NMR Meets Tau: Insights into Its Function and PathologyTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseAnalyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesTau pathology-mediated presynaptic dysfunctionLocal Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor Stimulation.Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside.The Study of Postmortem Human Synaptosomes for Understanding Alzheimer's Disease and Other Neurological Disorders: A Review.Internalization of the Extracellular Full-Length Tau Inside Neuro2A and Cortical Cells Is Enhanced by Phosphorylation.Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of diseaseThe CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathiesNeuroepigenetic mechanisms in disease.Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat.The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro.Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain.Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with ageA Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's DiseaseRetromer in Synaptic Function and Pathology
P2860
Q26747418-5544F438-C46F-4606-82FD-8EFF40F84325Q26773154-94D61424-42F4-4D05-81D2-3D60A15BC3CAQ28087158-9292C731-F4A6-4FD4-947F-2A0920E7BE66Q36951523-6778B4DF-E30A-4468-9889-71952906BDCEQ38752742-4815E03F-90D2-4A05-9190-9E53D3388BE4Q39085129-B8CE26C2-B076-42C1-858E-CD3843521D74Q39236946-E515D96D-F1AE-4685-91B3-4F84EB8E544BQ39432592-65EB77D9-F638-42E3-9894-932BEF2715DEQ39451622-E65E8A60-5874-439F-9F88-3F507824CE5BQ41201550-915493A6-EE3A-4580-8609-A3D5B1307D73Q41395309-86C3D940-DC0F-40A0-B893-7F2306986FA9Q42279018-BD4FEECC-2F0F-4EE9-AFD3-242660EB0529Q42371467-F7B08E25-131B-4528-AF61-A682DA587F68Q42690788-C39AD615-52AF-44BC-AAF1-6C8951D5FE89Q46237544-8A9D9017-38E4-48FC-BEA3-7C9FA560658CQ47137171-2772E68A-D843-4C38-9185-B131339A23C8Q47255855-6081ADED-72C6-4DC8-AE6B-FC56D7CC7225Q52315334-24817A11-AD9F-44E6-8CF9-1144275BAF8BQ53398002-EA71D36B-D62D-4FCD-9083-0CF54609B477Q57472629-4A752870-FE2A-48D2-A16E-E1D2C5B0027FQ57927766-5BED47AF-1B39-44BC-8E58-651A0CC5CA29Q58567253-E2547563-0D05-4FE1-A5CD-CE0D43561623
P2860
Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@ast
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@en
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@nl
type
label
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@ast
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@en
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@nl
prefLabel
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@ast
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@en
Frequent and symmetric deposit ...... minals in Alzheimer's disease.
@nl
P2093
P2860
P50
P1476
Frequent and symmetric deposit ...... rminals in Alzheimer's disease
@en
P2093
Bradley T Hyman
Matthew P Frosch
P2860
P356
10.1186/PREACCEPT-9134577561374599
10.1186/S40478-014-0146-2
P577
2014-10-21T00:00:00Z